Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $60.1 million.

  • Select Medical Holdings' Cash & Equivalents fell 6863.5% to $60.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.1 million, marking a year-over-year decrease of 6863.5%. This contributed to the annual value of $59.7 million for FY2024, which is 1341.77% up from last year.
  • Per Select Medical Holdings' latest filing, its Cash & Equivalents stood at $60.1 million for Q3 2025, which was down 6863.5% from $52.3 million recorded in Q2 2025.
  • Over the past 5 years, Select Medical Holdings' Cash & Equivalents peaked at $803.5 million during Q2 2021, and registered a low of $52.3 million during Q2 2025.
  • Over the past 5 years, Select Medical Holdings' median Cash & Equivalents value was $94.7 million (recorded in 2022), while the average stood at $197.0 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 92548.28% in 2021, then plummeted by 8821.78% in 2022.
  • Quarter analysis of 5 years shows Select Medical Holdings' Cash & Equivalents stood at $74.3 million in 2021, then soared by 31.75% to $97.9 million in 2022, then tumbled by 46.24% to $52.6 million in 2023, then increased by 13.42% to $59.7 million in 2024, then rose by 0.6% to $60.1 million in 2025.
  • Its Cash & Equivalents was $60.1 million in Q3 2025, compared to $52.3 million in Q2 2025 and $53.2 million in Q1 2025.